Prognostic evaluation of pancreatic cancer based on the model of chemo-radiotherapy resistance-related genes.

This study established and validated a prognostic signature of pancreatic cancer using nine CRRGs. The and experiments showed that could promote the proliferation and chemoradiotherapy tolerance of pancreatic cancer cell lines. These findings may offer new insights into the role of CRRGs in pancreatic cancer and provide novel prognostic biomarkers for the treatment of pancreatic cancer.